Latest stories

  • in

    Beta Testing Pfizer’s COVID-19 Vaccine

    We get the Businessweek Agenda with Bloomberg Intelligence Chief Equity Strategist Gina Martin Adams and Bloomberg Stocks Editor Dave Wilson. Bloomberg News Venture Capital Reporter Sarah McBride talks about beta testing Pfizer’s COVID-19 vaccine.   More

  • in

    Bloomberg Businessweek Weekend-October 17, 2020

    Featuring some of our favorite conversations of the week, from our daily radio show “Bloomberg Businessweek.” Hosted by Carol Massar and Paul Sweeney. Producer: Doni Holloway. Hear the show live at 2PM ET on WBBR 1130 AM New York, Bloomberg 106.1 FM Boston, Bloomberg 960 AM San Francisco, WDCH 99.1 FM in Washington D.C.   More

  • in

    Apple Introduces iPhone 12 With 5G

    Dr. Ian Lustbader, Clinical Professor of Medicine at NYU, provides a coronavirus and vaccine update. Bloomberg News White House Correspondent Josh Wingrove talks about President Trump undercutting a campaign reset as he weighs the prospect of defeat.   More

  • in

    Businessweek Extra-Cliff Hudson

    Cliff Hudson, former CEO of Sonic, discusses his leadership book “Master of None: How a Jack-of-All-Trades Can Still Reach the Top.” He also shares his view on traits that define effective leadership.   More

  • in

    Impact of Lack of Stimulus on U.S. Economy

    Bloomberg News Finance Reporter Jenny Surane discusses Wall Street traders taking home smaller slices in a banner year. Bloomberg Medical Science Reporter Michelle Cortez provides a coronavirus and vaccine update. Bloomberg Businessweek Editor Joel Weber and Bloomberg News Reporter Ari Altstedter talk about an Indian-made motorcycle with a retro look that is coming after Harley.   More

  • in

    The $120B Idea Behind the 2020 Nobel Prize in Economics

    Dr. Lisa Danzig, Chief Medical Advisor at CETF, discusses a clinical trial that has identified a new COVID-19 treatment called Fluvoxamine. Bloomberg Businessweek Editor Joel Weber and Businessweek Economics Editor Peter Coy talk about the $120 billion idea behind this year’s Nobel Prize in economics.   More

  • in

    Bank Earnings Roll In, Florida Seniors Could Seal Trump’s Election Fate

    Bloomberg Intelligence Chief Equity Strategist Gina Martin Adams and Bloomberg Stocks Editor Dave Wilson set the Businessweek Agenda. We breakdown bank earnings with Anton Schutz, President at Mendon Capital Advisors. Bloomberg Businessweek Editor Joel Weber and Bloomberg Businessweek National Correspondent Josh Green discuss Josh’s story on how a surge of early votes from seniors in Florida has put Joe Biden ahead in the critical battleground state.   More

  • in

    Tonix Pharmaceuticals CEO on COVID-19 Vaccine Progress

    Dr. Seth Lederman, CEO and Chairman of Tonix Pharmaceuticals, discusses working to develop a COVID-19 vaccine for clinical trials. Bloomberg Businessweek Editor Joel Weber and Bloomberg Finance reporter Michelle Davis walk through the story “PPP Scammers Made Fintech Companies Their Lenders of Choice.”   More

  • in

    Bloomberg Businessweek Weekend-October 10, 2020

    Featuring some of our favorite conversations of the week, from our daily radio show “Bloomberg Businessweek.” Hosted by Carol Massar and Jason Kelly. Producer: Doni Holloway. Hear the show live at 2PM ET on WBBR 1130 AM New York, Bloomberg 106.1 FM Boston, Bloomberg 960 AM San Francisco, WDCH 99.1 FM in Washington D.C.   More

  • in

    Using Data to Create a Safe Back-to-School Plan

    Dr. Ian Lustbader, Clinical Professor of Medicine at NYU, provides a coronavirus and vaccine update. He also discusses the latest COVID-19 treatments administered to President Trump. Bloomberg News Senior Trade and Globalization Reporter Shawn Donnan talk about two Cleveland houses that tell a story of America’s unequal recovery.   More